Mapi is seeking to expand its existing partnership base with companies that have complementing capabilities in technology, IP and market access
Collaborations
- Mapi has two JVs with Chinese pharmaceutical companies, for co-development and marketing of complex generic products for the global and Chinese markets.
- Recently, Mapi signed an agreement with one of the leading pharmaceutical companies for a development of a new controlled release dosage form based on Mapi's IP and know-how.